|
End-of-day quote
TEL AVIV STOCK EXCHANGE
30/10/2026
|
5-day change | 1st Jan Change | ||
| 1,792.00 ILa | +1.70% |
|
-3.34% | - |
| 07-14 | Rafa Laboratories Ltd. has completed an IPO in the amount of ILS 549.8718 million. | CI |
| 07-09 | Rafa Laboratories Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
TEL AVIV STOCK EXCHANGEILa
| Markets | Quality | ||
|---|---|---|---|
TEL AVIV STOCK EXCHANGE
| RAFA | End-of-day quote | |
TEL AVIV STOCK EXCHANGE
| RAFA | Delayed |
| 1 day | +1.70% | ||
| 1 week | -3.34% | ||
| Current month | -1.05% | ||
| 1 month | -1.05% | ||
| 3 months | +10.82% |
| 1 week | 1,671 |  | 1,865 |
| 1 month | 1,577 | | 1,868 |
| Current year | 1,401 | | 1,999 |
| 1 year | 1,401 | | 1,999 |
| 3 years | 1,401 | | 1,999 |
| 5 years | 1,401 | | 1,999 |
| 10 years | 1,401 | | 1,999 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ido Leshem
CEO | Chief Executive Officer | 50 | 01/01/2024 |
Gabi Hazan
COO | Chief Operating Officer | 58 | 01/01/2007 |
Yael Paula Tomer
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gillon Beck
BRD | Director/Board Member | 64 | 31/12/2020 |
Abraham Dadon
BRD | Director/Board Member | 70 | 27/05/2026 |
Amir Levin
BRD | Director/Board Member | 60 | 26/06/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.70% | -3.34% | - | - | 555M | |
| +3.19% | +11.31% | +67.86% | +150.58% | 1,224B | |
| -0.73% | +3.56% | +44.51% | +85.81% | 662B | |
| +1.41% | +3.24% | +29.22% | +107.83% | 514B | |
| +0.42% | +3.20% | +54.15% | +67.18% | 388B | |
| +2.18% | +2.93% | +73.30% | +45.62% | 361B | |
| +1.12% | +4.52% | +35.30% | +58.08% | 302B | |
| +6.96% | +8.86% | +11.27% | +36.62% | 271B | |
| +1.15% | +6.09% | +59.59% | +77.06% | 249B | |
| +3.06% | +9.38% | +44.11% | +119.47% | 205B | |
| Average | +1.73% | +4.71% | +46.59% | +83.14% | 417.74B | |
| Weighted average by Cap. | +1.17% | +6.35% | +50.91% | +98.22% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 420M 0 134M 120M 110M 99.76M 186M 12.69B 190M 1.31B 527M 6.68B 502M 491M 21.05B | 418M 0 133M 119M 110M 99.37M 186M 12.64B 189M 1.31B 525M 6.65B 500M 489M 20.97B |
| Net income | 99.43M 0 31.63M 28.33M 26.06M 23.61M 44.14M 3B 44.96M 311M 125M 1.58B 119M 116M 4.98B | 100M 0 31.92M 28.59M 26.3M 23.83M 44.54M 3.03B 45.37M 314M 126M 1.59B 120M 117M 5.03B |
| Net Debt | - | - |
Employees
257
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | ILA 1,792.00 | +1.70% | 3,475 |
| 29/10/26 | ILA 1,762.00 | +0.11% | 5,431 |
| 28/10/26 | ILA 1,760.00 | -5.12% | 12,581 |
| 26/10/26 | ILA 1,855.00 | +0.05% | 37,374 |
| 23/10/26 | ILA 1,854.00 | +0.98% | 1,760 |
- Stock Market
- Stocks
- RAFA Stock
Select your edition
All financial news and data tailored to specific country editions
